Complejo Hospitalario de Toledo -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

    European Journal of Endocrinology, Vol. 177, Núm. 4, pp. 309-317